Top of the morning to you, and a fine one it is. How so? A warm and shiny sun is dissipating the chilly wintry air enveloping the Pharmalot campus, where the short people have left for their productive pursuits and we are surrounded by snoozing mascots. This is another way of saying we are left to proceed on our usual hunt for items of interest. So time to get cracking. Grab a cup of stimulation or, if you prefer, a bottle of water and enjoy the tidbits collected below. Hope your day is challenging and rewarding. And of course, do keep us in mind when interesting things pop …

Boehringer Ingelheim will eliminate more than 10 percent of its staff in France — 327 positions, which includes 197 in human health and 130 in its animal health unit, Pharmaphorum writes. The move comes nearly two years after the company acquired the Sanofi (SNY) animal health unit in exchange for its consumer health division. All told, Boehringer employs 2,800 employees in France across both divisions. The cuts come on the heels of plans by Sanofi to axe 670 jobs in France.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy